BIO products
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800070P
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,849
Award facts
- Contract value 100% obligated
- $7,849.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94566, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $7,849.00 in bio products on December 12, 2017, with an ultimate completion date of January 12, 2018. Work is performed in Pleasanton, California. The order is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract HHSN261201800070P?
HHSN261201800070P was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on December 12, 2017.
How much is contract HHSN261201800070P worth?
The government has obligated $7,849 on HHSN261201800070P.
Was contract HHSN261201800070P competed?
The extent of competition for HHSN261201800070P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award